Cdc hiv post exposure prophylaxis

Post-Exposure Prophylaxis (PEP) | HIV Risk and Prevention ...

Cdc.govInterim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP). Please see attached PDF pdf icon [PDF – 104 KB] . PEP is the use of antiretroviral drugs after a single high-risk event to stop HIV seroconversion.

https://www.cdc.gov/hiv/risk/pep/index.html 

Pre-Exposure Prophylaxis (PrEP) and Post-Exposure ...

Cdc.govPrEP is a prevention method used by people who are HIV-negative and at high risk for being exposed to HIV through sexual contact or injection drug use. When someone is exposed to HIV through sex or injection drug use, these medicines can work to keep the virus from establishing an infection.

https://www.cdc.gov/hiv/clinicians/prevention/prep-and-pep.html 

Post-Exposure Prophylaxis (PEP) - Centers for Disease ...

Cdc.govPatients at high risk for HIV may be able to take advantage of newer medicines prescribed by their healthcare providers for pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). PEP is the use of antiretroviral medication to prevent HIV infection in an HIV-negative person who has had a specific high-risk exposure to HIV.

https://www.cdc.gov/hiv/clinicians/prevention/pep.html 

Post-Exposure Prophylaxis (PEP): Definition, Side Effects ...

Webmd.comPost-exposure prophylaxis (PEP) is medicine you take after you’ve come into contact with HIV, the virus that causes AIDS, to lower your chance of infection. You must start PEP within 72 hours (3 ...

https://www.webmd.com/hiv-aids/post-exposure-prophylaxis 

Welcome to CDC stacks

Stacks.cdc.govInterim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP). Please see attached statement (PDF of Dolutegravir attached) From the Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.

https://stacks.cdc.gov/view/cdc/38856 

Hotlines and Referrals | Resource Library | HIV/AIDS | CDC

Cdc.govThe Perinatal HIV Consultation and Referral Service also links HIV-infected pregnant women with appropriate health care. 1-888-448-8765 | 24 Hours/Day and Voicemail. PEPline. Provides expert guidance in managing health care worker exposures to HIV and hepatitis B and C. Callers receive immediate post-exposure prophylaxis (PEP) recommendations.

https://www.cdc.gov/hiv/library/hotlines.html 

PEP | HIV Basics | HIV/AIDS | CDC

Cdc.govPEP stands for post-exposure prophylaxis. It means taking antiretroviral medicines (ART) after being potentially exposed to HIV to prevent becoming infected. PEP must be started within 72 hours after a recent possible exposure to HIV, but the sooner you start PEP, the better. Every hour counts.

https://www.cdc.gov/hiv/basics/pep.html 

Guidelines and Recommendations | HIV/AIDS | CDC

Cdc.govGuidance for Non-HIV-Specialized Providers Caring for Persons with HIV Who Have been Displaced by Disasters (such as a Hurricane) external icon Update (May 23, 2018) Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP) pdf icon [PDF – 104 KB] .

https://www.cdc.gov/hiv/guidelines/index.html 

Post-Exposure Prophylaxis | HIV.gov

Hiv.govPEP, or post-exposure prophylaxis, is a short course of HIV medicines taken very soon after a possible exposure to HIV to prevent the virus from taking hold in your body. You must start it within 72 hours after you were exposed to HIV, or it won’t work. Every hour counts. PEP should be used only in emergency situations.

https://www.hiv.gov/hiv-basics/hiv-prevention/using-hiv-medication-to-reduce-risk/post-exposure-prophylaxis